Anesthesia Clinical Trial
Official title:
The Influence of Age on Bispectral Index Associated With Propofol-induced Sedation
The bispectral index (BIS) is commonly used in anesthesia to evaluate the depth of sedation.
Numerous studies in adults have shown good correlation between bispectral index values and
depth of sedation regardless of the hypnotic drug used. Requirements of intravenous and
inhalational hypnotic agents to suppress consciousness decrease with age. A study showed
that the loss of consciousness (LOC) was obtained with lower concentrations of sevoflurane
in elderly than in young adults, but at identical BIS values, so that BIS would predict
depth of sedation better than drug monitoring. This result incited the use of bispectral
index monitoring to overcome the significant pharmacological variability, especially in
elderly. Nevertheless, another research with a comparable methodology during
propofol-induced anaesthesia provided higher BIS values at LOC in elderly compared to
younger patients. In these two trials, LOC was defined differently: either by absence of
verbal response corresponding to loss of eyelash reflex (LOER) or by absence of response to
prodding [(OAA/S) <2)]. Otherwise electromyographic activity (EMG) was not taken in account.
As high EMG level (greater than 50 decibels) could create subtle artifact signal pollution
without necessarily being displayed as artifacts, this would be misinterpreted by the BIS
algorithm as EEG activity and assigned a spuriously increased BIS value.
The main objective of our study was to specifically evaluate BIS values according to age
during propofol-induced sedation. LOC was measured by obtaining an OAA/S score <2 (OAA/S2),
or a deeper sedation criterion: loss of eyelash reflex (LOER). The secondary objective was
to specify the influence of EMG on the displayed BIS values and its age-related
modifications.
The study was approved by the ethics committee of the Saint-Etienne University Hospital.
After informed consent, 70 patients over 18 years of age, ASA I to III, scheduled to undergo
orthopaedic surgery under general anaesthesia were included.
Exclusion criteria were the presence of heart, respiratory, hepatic or renal failure; a
psychiatric or neurological pathology, severe depression or dementia; gastro-oesophageal
reflux, hiatal hernia; drug addiction or chronic alcoholism; obesity with a body mass index
greater than 30.
The patients received no pre-medication. After insertion of a venous line, a Ringer's
Lactate perfusion was initiated. Oxygen therapy at a rate of 4 litres per minute was
administered in spontaneous ventilation. In case of hypoventilation (saturation (SaO2) <95%
and/or end-tidal carbon dioxide concentration (EtCO2) >42 mmHg, manual ventilation with a
mask at 10 l/min of O2 was administered.
Propofol was administered using a commercially available target-controlled infusion with an
incorporated pharmacokinetic model developed by Schnider (Base Primea , Fresenius-Kabi,
Brezins, FRANCE). The initial effect-site target concentration of propofol (0.5 μg/ml) was
incremented by 0.5 μg/ml every 5 minutes to ensure equilibration between plasma
concentration and effect site, until LOER. From the beginning of infusion until LOER
patients received no other agent besides propofol for the duration of the trial.
LOC was evaluated by an independent observer using two different criteria: OAA/S score <2
(OAA/S2) corresponding to the absence of response to moderate prodding and LOER.
To minimize interactions between verbal or tactile stimulations and BIS values, BIS values
were collected before evaluation of the OAA/S score and eyelash reflex check. Time to OAA/S2
and time to LOER were measured as well as corresponding brain and plasma concentrations of
propofol.
Electroencephalographic activity was monitored by BIS Quatro XP platform® electrodes and a
BIS VISTA™ 1.01 monitor (Aspect medical system, MA, USA). The impedance of each electrode
was kept below 5 kΩ. The sensor were reapplied if the quality of the detected signal was not
suitable to provide a reliable BIS score i.e a signal quality index (SQI) better than 50%.
The trace was displayed in real time and calculated data (BIS, SQI, and EMG) were recorded
continuously using the archiving function integrated in the monitor. A 30 second smoothing
period was set to minimize the variability and sensitivity of artifacts. BIS values were
validated throughout the trial by SQI values greater than 90.
Before induction and at the end of each propofol concentration level, BIS, EMG and SQI
values were recorded. As soon as the OAA/S score was less than or equal to 4, the OAA/S
score and eyelash reflex were evaluated every 2 minutes independently of the increase in
effect-site concentration of propofol.
Arterial pressure, heart rate, SaO2, EtCO2 were measured before induction and then every 5
minutes until the end of trial. A decrease in systolic arterial pressure ≥20 was considered
as hypotension, and heart rate <45 defined bradycardia.
Patients were included consecutively and assigned to one of the two groups according to
their age: "young" 18 to 64 years (G1) and "elderly" aged 65 years and over (G2). As
previously described, we considered that a difference of 15 units between the mean BIS
values at LOC according to age was clinically pertinent.
Calculation of the required number of subjects was carried out to identify a difference of
15 units in the mean BIS value at LOC between both groups with a power of 90%, a 5% alpha
risk, and an identical variability for these 2 groups (SD = 20). Thirty-five patients have
to be included in each group.
The qualitative data were compared by a chi-squared test or when indicated by a Fisher's
exact test. After verification of the normality of their distribution by a Kolmogorov
Smirnov test, quantitative data were compared by a Student's t-test. A linear regression was
used to measure the effect of age on BIS and EMG values at OAA/S2 and LOER. All the
statistical analysis were performed using JMP 6 (SAS Institute Inc, Carry, NC, USA). Values
p< 0.05 was considered to be statistically significant.
;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04580030 -
Tricuapid Annular Plane Sistolic Excursion Before General Anesthesia Can Predict Hypotension After Induction
|
||
| Active, not recruiting |
NCT04279054 -
Decreased Neuraxial Morphine After Cesarean Delivery
|
Early Phase 1 | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Recruiting |
NCT04099693 -
A Prospective Randomized Study of General Anesthesia Versus Anesthetist Administered Sedation for ERCP
|
||
| Terminated |
NCT02481999 -
Pre- and Postoperative EEG-Monitoring for Children Aged From 0,5 to 8 Years
|
||
| Completed |
NCT04235894 -
An Observer Rating Scale of Facial Expression Can Predict Dreaming in Propofol Anesthesia
|
||
| Recruiting |
NCT05525104 -
The Effect of DSA on Recovery of Anaesthesia in Children (Het Effect Van DSA op Het Herstel na Anesthesie Bij Kinderen).
|
N/A | |
| Recruiting |
NCT05024084 -
Desflurane and Sevoflurane Minimal Flow Anesthesia on Recovery and Anesthetic Depth
|
Phase 4 | |
| Completed |
NCT04204785 -
Noise in the OR at Induction: Patient and Anesthesiologists Perceptions
|
N/A | |
| Completed |
NCT03277872 -
NoL, HR and MABP Responses to Tracheal Intubation Performed With MAC Blade Versus Glidescope
|
N/A | |
| Terminated |
NCT03940651 -
Cardiac and Renal Biomarkers in Arthroplasty Surgery
|
Phase 4 | |
| Terminated |
NCT02529696 -
Measuring Sedation in the Intensive Care Unit Using Wireless Accelerometers
|
||
| Completed |
NCT05346588 -
THRIVE Feasibility Trial
|
Phase 3 | |
| Terminated |
NCT03704285 -
Development of pk/pd Model of Propofol in Patients With Severe Burns
|
||
| Recruiting |
NCT05259787 -
EP Intravenous Anesthesia in Hysteroscopy
|
Phase 4 | |
| Completed |
NCT02894996 -
Does the Response to a Mini-fluid Challenge of 3ml/kg in 2 Minutes Predict Fluid Responsiveness for Pediatric Patient?
|
N/A | |
| Completed |
NCT05386082 -
Anesthesia Core Quality Metrics Consensus Delphi Study
|
||
| Terminated |
NCT03567928 -
Laryngeal Mask in Upper Gastrointestinal Procedures
|
N/A | |
| Recruiting |
NCT06074471 -
Motor Sparing Supraclavicular Block
|
N/A | |
| Completed |
NCT04163848 -
CARbon Impact of aNesthesic Gas
|